227 related articles for article (PubMed ID: 20194526)
1. Cognition-enhancing properties of Dimebon in a rat novel object recognition task are unlikely to be associated with acetylcholinesterase inhibition or N-methyl-D-aspartate receptor antagonism.
Giorgetti M; Gibbons JA; Bernales S; Alfaro IE; Drieu La Rochelle C; Cremers T; Altar CA; Wronski R; Hutter-Paier B; Protter AA
J Pharmacol Exp Ther; 2010 Jun; 333(3):748-57. PubMed ID: 20194526
[TBL] [Abstract][Full Text] [Related]
2. Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: a microdialysis study.
Shearman E; Rossi S; Szasz B; Juranyi Z; Fallon S; Pomara N; Sershen H; Lajtha A
Brain Res Bull; 2006 Mar; 69(2):204-13. PubMed ID: 16533671
[TBL] [Abstract][Full Text] [Related]
3. Effects of memantine and donepezil on cortical and hippocampal acetylcholine levels and object recognition memory in rats.
Ihalainen J; Sarajärvi T; Rasmusson D; Kemppainen S; Keski-Rahkonen P; Lehtonen M; Banerjee PK; Semba K; Tanila H
Neuropharmacology; 2011; 61(5-6):891-9. PubMed ID: 21704049
[TBL] [Abstract][Full Text] [Related]
4. Co-administration of memantine has no effect on the in vitro or ex vivo determined acetylcholinesterase inhibition of rivastigmine in the rat brain.
Enz A; Gentsch C
Neuropharmacology; 2004 Sep; 47(3):408-13. PubMed ID: 15275830
[TBL] [Abstract][Full Text] [Related]
5. Dimebolin is a 5-HT6 antagonist with acute cognition enhancing activities.
Schaffhauser H; Mathiasen JR; Dicamillo A; Huffman MJ; Lu LD; McKenna BA; Qian J; Marino MJ
Biochem Pharmacol; 2009 Oct; 78(8):1035-42. PubMed ID: 19549510
[TBL] [Abstract][Full Text] [Related]
6. In vitro galantamine-memantine co-application: mechanism of beneficial action.
Zhao X; Marszalec W; Toth PT; Huang J; Yeh JZ; Narahashi T
Neuropharmacology; 2006 Dec; 51(7-8):1181-91. PubMed ID: 17011596
[TBL] [Abstract][Full Text] [Related]
7. Memantine blocks alpha7* nicotinic acetylcholine receptors more potently than n-methyl-D-aspartate receptors in rat hippocampal neurons.
Aracava Y; Pereira EF; Maelicke A; Albuquerque EX
J Pharmacol Exp Ther; 2005 Mar; 312(3):1195-205. PubMed ID: 15522999
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology of acetylcholinesterase inhibitors and N-methyl-D-aspartate receptors for combination therapy in the treatment of Alzheimer's disease.
Geerts H; Grossberg GT
J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):8S-16S. PubMed ID: 16809810
[TBL] [Abstract][Full Text] [Related]
9. Modulation of N-methyl-D-aspartate receptors by donepezil in rat cortical neurons.
Moriguchi S; Zhao X; Marszalec W; Yeh JZ; Narahashi T
J Pharmacol Exp Ther; 2005 Oct; 315(1):125-35. PubMed ID: 15951396
[TBL] [Abstract][Full Text] [Related]
10. In vivo pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107: preclinical considerations in Alzheimer's disease.
Bitner RS; Bunnelle WH; Decker MW; Drescher KU; Kohlhaas KL; Markosyan S; Marsh KC; Nikkel AL; Browman K; Radek R; Anderson DJ; Buccafusco J; Gopalakrishnan M
J Pharmacol Exp Ther; 2010 Sep; 334(3):875-86. PubMed ID: 20504913
[TBL] [Abstract][Full Text] [Related]
11. Activation of brain histaminergic neurotransmission: a mechanism for cognitive effects of memantine in Alzheimer's disease.
Motawaj M; Burban A; Davenas E; Arrang JM
J Pharmacol Exp Ther; 2011 Feb; 336(2):479-87. PubMed ID: 21057059
[TBL] [Abstract][Full Text] [Related]
12. SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models.
Hirst WD; Stean TO; Rogers DC; Sunter D; Pugh P; Moss SF; Bromidge SM; Riley G; Smith DR; Bartlett S; Heidbreder CA; Atkins AR; Lacroix LP; Dawson LA; Foley AG; Regan CM; Upton N
Eur J Pharmacol; 2006 Dec; 553(1-3):109-19. PubMed ID: 17069795
[TBL] [Abstract][Full Text] [Related]
13. Brain levels and acetylcholinesterase inhibition with galantamine and donepezil in rats, mice, and rabbits.
Geerts H; Guillaumat PO; Grantham C; Bode W; Anciaux K; Sachak S
Brain Res; 2005 Feb; 1033(2):186-93. PubMed ID: 15694923
[TBL] [Abstract][Full Text] [Related]
14. Lack of pharmacokinetic or pharmacodynamic interaction between memantine and donepezil.
Periclou AP; Ventura D; Sherman T; Rao N; Abramowitz WT
Ann Pharmacother; 2004 Sep; 38(9):1389-94. PubMed ID: 15266045
[TBL] [Abstract][Full Text] [Related]
15. Study of neuroprotection of donepezil, a therapy for Alzheimer's disease.
Akasofu S; Kimura M; Kosasa T; Sawada K; Ogura H
Chem Biol Interact; 2008 Sep; 175(1-3):222-6. PubMed ID: 18571635
[TBL] [Abstract][Full Text] [Related]
16. Therapeutically relevant plasma concentrations of memantine produce significant L-N-methyl-D-aspartate receptor occupation and do not impair learning in rats.
Morè L; Gravius A; Nagel J; Valastro B; Greco S; Danysz W
Behav Pharmacol; 2008 Oct; 19(7):724-34. PubMed ID: 18797249
[TBL] [Abstract][Full Text] [Related]
17. Two novel 5-HT6 receptor antagonists ameliorate scopolamine-induced memory deficits in the object recognition and object location tasks in Wistar rats.
de Bruin NM; Prickaerts J; van Loevezijn A; Venhorst J; de Groote L; Houba P; Reneerkens O; Akkerman S; Kruse CG
Neurobiol Learn Mem; 2011 Sep; 96(2):392-402. PubMed ID: 21757018
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of action of galantamine on N-methyl-D-aspartate receptors in rat cortical neurons.
Moriguchi S; Marszalec W; Zhao X; Yeh JZ; Narahashi T
J Pharmacol Exp Ther; 2004 Sep; 310(3):933-42. PubMed ID: 15121761
[TBL] [Abstract][Full Text] [Related]
19. Dose-dependent effect of CDPPB, the mGluR5 positive allosteric modulator, on recognition memory is associated with GluR1 and CREB phosphorylation in the prefrontal cortex and hippocampus.
Uslaner JM; Parmentier-Batteur S; Flick RB; Surles NO; Lam JS; McNaughton CH; Jacobson MA; Hutson PH
Neuropharmacology; 2009; 57(5-6):531-8. PubMed ID: 19627999
[TBL] [Abstract][Full Text] [Related]
20. Comparative studies of huperzine A, donepezil, and rivastigmine on brain acetylcholine, dopamine, norepinephrine, and 5-hydroxytryptamine levels in freely-moving rats.
Liang YQ; Tang XC
Acta Pharmacol Sin; 2006 Sep; 27(9):1127-36. PubMed ID: 16923332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
